Nemaura Medical Inc. (NMRD)

Market Cap	4.04K
Revenue (ttm)	n/a
Net Income (ttm)	-10.65M
Shares Out	40.35M
EPS (ttm)	-0.38
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	80,880
Open	0.0056
Previous Close	0.0056
Day's Range	0.0040 - 0.0056
52-Week Range	0.0030 - 0.3000
Beta	-0.04
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 12, 2024

About Nemaura Medical

Nemaura Medical Inc., a medical technology company, manufactures continuous glucose monitoring system in the United States. It offers sugarBEAT, a non-invasive continuous glucose monitoring device for use by persons with Type I and Type II diabetes, as well as screen pre-diabetic patients. The company also offers proBEAT, a wellness guidance notes, that provide prompts and educate users on factors affecting blood sugar profiles, as well as conducts diabetes prevention and reversal programs. Nemaura Medical Inc. was founded in 2009 and is based ...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2009
• Employees: 36
• Stock Exchange: OTCMKTS
• Ticker Symbol: NMRD

Financial Performance

In 2022, Nemaura Medical's revenue was $77,044, a decrease of -84.71% compared to the previous year's $503,906. Losses were -$14.14 million, 1.85% more than in 2021.